Tumor Immunotherapy Using A<sub>2A</sub> Adenosine Receptor Antagonists

Tumor Immunotherapy Using A<sub>2A</sub> Adenosine Receptor Antagonists

The A<sub>2A</sub> adenosine receptor (A<sub>2A</sub>AR) plays critical roles in human physiology and pathophysiology, which makes it an important drug target. Previous drug-discovery efforts targeting the A<sub>2A</sub>AR have been focused on the use of A<sub&...

Full description

Bibliographic Details
Main Authors: Jinfeng Zhang, Wenzhong Yan, Wenwen Duan, Kurt Wüthrich, Jianjun Cheng
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pharmaceuticals
Subjects:
GPCR
immuno-oncology
Parkinson’s disease
drug binding modes
cancer therapy
Online Access:https://www.mdpi.com/1424-8247/13/9/237

Internet

https://www.mdpi.com/1424-8247/13/9/237

Similar Items